PARIS, March 12 (Reuters) - French drug agency ANSM said on
Friday it agreed with the European Medicines Agency to continue
using the COVID-19 vaccine developed by AstraZeneca.
ANSM agency also said it was starting a study on the safety
of COVID-19 vaccines available in France.
(Reporting by Jean-Stephane Brosse, Geert De Clercq and
Matthieu Protard; Editing by Alison Williams)